Approval · Notice of Compliance 34608 · 2024
VABOMERE: Notice of Compliance 34608
Issued December 20, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34608
- Date
- December 20, 2024
- Company
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VABOMERE | 02554151 | Marketed |
Medicinal ingredients
- MEROPENEM TRIHYDRATE 1 G per VIAL
- VABORBACTAM 1 G per VIAL